Cross Country Healthcare, Inc. (NASDAQ:CCRN) Receives Consensus Recommendation of "Hold" from Brokerages
Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received a consensus "Hold" rating from nine brokerages, with an average 12-month price target of $12.53. The company recently missed its quarterly earnings estimates and provided lower-than-expected Q1 2026 guidance, while its stock trades near $9.52. Despite negative earnings, institutional ownership is high at 96.03%, with major firms increasing their stakes.
Precision Trading with Cross Country Healthcare Inc. (CCRN) Risk Zones
This article from Stock Traders Daily provides a detailed AI-driven analysis for Cross Country Healthcare Inc. (CCRN), highlighting a near-term weak sentiment that may signal a resumption of long-term weakness. It identifies an exceptional 88.5:1 risk-reward setup, targeting a 20.8% gain versus 0.2% risk, and outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for various risk profiles. The analysis includes entry zones, targets, and stop-loss levels based on multi-timeframe signal analysis.
CCRN PE Ratio & Valuation, Is CCRN Overvalued
Cross Country Healthcare Inc (CCRN) is currently undervalued according to Intellectia's analysis, with its fair price estimated between $17.75 and $22.56 compared to its current price of $9.18. The company's valuation metrics, including its P/S ratio of 0.29, suggest it is significantly undervalued relative to its five-year average and industry competitors. However, despite the undervaluation, its revenue growth is negative, and its P/S ratio is above the industry average when considering competitors' benchmarks.
CCRN SEC Filings - Cross Ctry Healthcare Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access official regulatory documents for Cross Country Healthcare Inc. (CCRN), including annual reports, quarterly earnings, material event disclosures, and insider trading forms. Stock Titan offers AI-powered summaries to help users quickly understand the key points of these complex documents and track regulatory and governance developments. The recent filings detail the 2025 Annual Meeting, the contingent nature of this meeting due to a pending merger with Aya Healthcare, and the automatic extension of the merger agreement's end date.
[DEFR14A] CROSS COUNTRY HEALTHCARE INC Revised Proxy Statement
Cross Country Healthcare, Inc. (CCRN) filed a revised proxy statement (DEFR14A) to correct extraneous language found in its previous Definitive Proxy Statement regarding "New Plan Benefits." The revision removes the extraneous text, and the company's recommendation for Proposal 4 remains unchanged. This supplement should be read in conjunction with the original proxy statement.
Cross Country (NASDAQ: CCRN) GC awarded 33,644 restricted shares
Cross Country Healthcare General Counsel Susan E. Ball was granted 33,644 restricted shares of common stock on March 31, 2026, which will vest in three equal installments by March 31, 2029. Additionally, 3,703 shares were withheld to cover tax obligations for previously vested restricted stock. After these transactions, Ball directly holds 241,777 shares of Cross Country Healthcare common stock.
CROSS COUNTRY HEALTHCARE (NASDAQ: CCRN) CFO awarded 47,873 RS shares, 5,313 withheld for taxes
CROSS COUNTRY HEALTHCARE (NASDAQ: CCRN) CFO William J. Burns was awarded 47,873 restricted shares of common stock, which will vest in three equal installments from 2027 to 2029. Additionally, 5,313 shares were withheld for tax obligations related to restricted stock that vested on March 31, 2026, at a value of $9.40 per share. Following these transactions, Burns directly holds 336,438 shares of the company's common stock, reflecting routine equity compensation rather than open-market trading.
CCRN SEC Filings - Cross Ctry Healthcare Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Cross Country Healthcare Inc. (CCRN) SEC filings, including annual 10-K reports, quarterly 10-Q reports, and current 8-K filings, with AI-powered summaries. Recent filings highlight the company's financial performance, investor meetings, insider transactions, and upcoming shareholder meeting details. The company experienced a significant net loss in Q4 and full-year 2025 due to softening demand and merger termination impacts.
Cross Country promotes exec to chief operating officer
Cross Country Healthcare has promoted Amiee Hawkins to Chief Operating Officer, following other significant leadership changes at the healthcare staffing firm. The company also saw the departure of its previous CEO and two other executives, while naming a new Chief Accounting Officer. This comes after the cancellation of its proposed merger with Aya Healthcare in December and positions Cross Country as the seventh-largest healthcare staffing firm.
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
Analysts predict a year-over-year decline in earnings for Cross Country Healthcare (CCRN) for the quarter ending December 2025, with an expected EPS of $0.03 and revenues of $252.25 million. Despite a recent upward revision in the consensus EPS estimate, the company's Zacks Earnings ESP of 0% and a Zacks Rank of #3 suggest it's difficult to conclusively predict an earnings beat. Investors are advised to consider other factors alongside these indicators.
[ARS] CROSS COUNTRY HEALTHCARE INC SEC Filing
This article announces an ARS SEC filing by CROSS COUNTRY HEALTHCARE INC (CCRN) on March 30, 2026. The filing has a low impact and neutral sentiment. The article also provides an overview of CCRN's stock data, recent news, and other SEC filings.
Cross Country Healthcare appoints Amiee Hawkins as chief operating officer
Cross Country Healthcare Inc. (NASDAQ:CCRN) has appointed Amiee Hawkins as its new chief operating officer, effective Saturday, March 29, 2026. Hawkins, 46, has served with the company since 2014 in various operational roles, and her new appointment does not involve changes to her compensation. This follows Cross Country Healthcare's recent reporting of lower-than-expected Q4 2025 earnings and revenue, leading to a reiterated Market Outperform rating from Citizens, and the departure of its Chief Information Officer.
Cross Country Healthcare Names Amiee Hawkins Chief Operating Officer
Cross Country Healthcare (CCRN) has appointed Amiee Hawkins as Chief Operating Officer, effective March 28, 2026. Hawkins' promotion, following a decade of rising operational roles, involves no new contracts or pay changes. TipRanks' AI Analyst, Spark, rates CCRN as Neutral due to weakened financial performance, despite low leverage and positive recent cash generation.
Cross Country Healthcare, Inc. Files Form 8-K with SEC – Company Details, Address, Stock Info, and Filing Summary
Cross Country Healthcare, Inc. announced the appointment of Amiee Hawkins as its new Chief Operating Officer, effective March 28, 2026. This internal promotion reflects stability in leadership, with Ms. Hawkins bringing extensive operational experience to the role. The company emphasized that there are no new compensation agreements or related party transactions associated with her appointment, which may be viewed positively by investors.
Cross Country Healthcare (CCRN) appoints Amiee Hawkins as new COO
Cross Country Healthcare, Inc. (CCRN) has appointed Amiee Hawkins as its new Chief Operating Officer, effective March 28, 2026. Ms. Hawkins has a long history with the company, having served in various senior operational roles since 2014, most recently as Chief Solutions and Operations Officer. Her appointment does not involve new agreements, changes to her compensation, or any related-party transactions.
Cross Country Healthcare appoints Amiee Hawkins as chief operating officer
Cross Country Healthcare (NASDAQ:CCRN) has appointed Amiee Hawkins as its new chief operating officer, effective Saturday, March 27. Hawkins, who has been with the company since 2014, previously served as chief solutions and operations officer. This announcement follows recent financial news for the company, including a fourth-quarter 2025 EPS and revenue miss and the departure of its Chief Information Officer.
CCRN SEC Filings - Cross Ctry Healthcare Inc 10-K, 10-Q, 8-K Forms
This page provides centralized access to Cross Country Healthcare (CCRN) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports, along with AI-powered summaries. Recent filings discuss the company's 2025 Annual Meeting, the anticipated closing of its merger with Aya Healthcare by Q4 2025, and Q2 2025 financial results showing a revenue decline but narrowed losses. The financial data also indicates the company remains debt-free with stable cash and equivalents.
Vanguard disaggregates holdings; Cross Country Healthcare (NASDAQ: CCRN) shows 0 shares
The Vanguard Group filed an amended Schedule 13G/A for Cross Country Healthcare (CCRN), reporting 0 shares beneficially owned and 0% of common stock. This change is due to an internal realignment on January 12, 2026, where subsidiaries will now report their beneficial ownership separately in reliance on SEC Release No. 34-39538. The filing, signed by Ashley Grim, Head of Global Fund Administration on March 26, 2026, indicates a procedural compliance update rather than a divestment of shares.
Cross Country Healthcare positions flexible labor as core to resilient healthcare workforce strategy
Cross Country Healthcare advocates for flexible labor models as a fundamental component of building a resilient healthcare workforce. The company stresses that flexible staffing is no longer a contingency but a core strategy for healthcare organizations to manage shifting demands, rising costs, and staffing shortages. Cross Country Healthcare has been actively promoting this approach to nurse leaders and strengthening its operational stability through initiatives like hiring a security engineer.
Cross Country Healthcare (CCRN) CAO discloses 19,140 common shares in Form 3
Cross Country Healthcare's Chief Accounting Officer, Marvin Veizaga, has filed a Form 3 disclosing an initial beneficial ownership of 19,140 shares of the company's common stock. This filing officially reports the existing holdings and does not indicate any new transactions such as purchases or sales. The Form 3 details his direct ownership in the company as an officer.
Cross Country Healthcare launches search for cybersecurity specialist amid growing risks
Cross Country Healthcare is actively recruiting a security engineer to bolster its cybersecurity defenses against increasing threats. The new role will be responsible for protecting critical systems, conducting vulnerability assessments, managing security incidents, and implementing data protection solutions. This initiative underscores the company's commitment to strengthening its security posture across its operations.
Technical Reactions to CCRN Trends in Macro Strategies
This article provides a technical analysis of Cross Country Healthcare Inc. (CCRN) focusing on its stock trends through AI-generated macro strategies. It identifies a mid-channel oscillation pattern and offers three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) tailored to different risk profiles. The analysis highlights divergent sentiment across various time horizons and provides key support and resistance levels for CCRN.
If You Invested $1,000 in Cross Ctry Healthcare Inc (CCRN)
This article analyzes the historical performance of a $1,000 investment in Cross Country Healthcare Inc (CCRN) over 1, 5, and 10 years, noting significant underperformance compared to the S&P 500. It also provides an in-depth overview of the company, including its business focus, segments, technology-driven approach, industry experience, and corporate developments such as the terminated merger agreement with Aya Healthcare. Financial data and annual returns are included, along with FAQs about investment returns and CAGR.
Cross Country Healthcare announces departure of chief information officer By Investing.com
Cross Country Healthcare announced that Phil Noe has ceased serving as Chief Information Officer, effective March 10, receiving $205,975 in severance. Mr. Noe will also provide consulting services at $198.04 per hour through May 31. This executive change follows recent financial challenges, including missed earnings and revenue targets, though InvestingPro analysis suggests the stock is undervalued.
Cross Country Healthcare CIO Departs, Assumes Advisory Role
Cross Country Healthcare (CCRN) announced that its CIO, Phil Noe, departed his role on March 10, 2026, and entered into a separation agreement on March 16, 2026. Noe will receive six months of severance pay and has been retained as a paid IT consultant through May 31, 2026, to ensure continuity during the leadership transition. Spark, TipRanks' AI Analyst, rates CCRN as Neutral due to weakened financial performance, offset by low leverage and positive recent cash generation.
Cross Country Healthcare (NASDAQ: CCRN) details CIO exit, $205,975 severance and consulting role
Cross Country Healthcare (NASDAQ: CCRN) has detailed the exit arrangements for former Chief Information Officer Phil Noe, who ceased serving as CIO on March 10, 2026. Under a Separation Agreement, Mr. Noe will receive $205,975 in severance, representing six months of his base salary. Additionally, an Independent Contractor Agreement engages him to provide technology consulting services from March 11, 2026, through May 31, 2026, at a rate of $198.04 per hour.
Cross Country Healthcare's Phil Noe exits as CIO; enters separation and consulting agreements
Phil Noe has exited his role as Chief Information Officer at Cross Country Healthcare, effective March 10, 2026. He has entered into both a separation agreement and a short-term consulting agreement to provide technology-related services. As part of the separation, he will receive $205,975 in severance and a consulting rate of $198.04 per hour until May 31, 2026.
Analysts Are Neutral on These Healthcare Stocks: Cross Country Healthcare (CCRN), HealthStream (HSTM)
Analysts have issued neutral ratings for Cross Country Healthcare (CCRN) and HealthStream (HSTM), indicating neither bullish nor bearish sentiment. Barrington analyst Kevin Steinke maintained a Hold rating for Cross Country Healthcare, with an average price target that suggests a 20.8% upside. Barrington analyst Vincent Colicchio also maintained a Hold rating for HealthStream, though the overall analyst consensus for HealthStream is a Moderate Buy with a 50.3% upside.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Given Consensus Rating of "Hold" by Brokerages
Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received a consensus "Hold" rating from nine brokerages, with an average 12-month price target of $12.03. This follows a disappointing Q4 2025 earnings report, where the company missed EPS and revenue estimates and provided weak Q1 2026 guidance. Institutional investors hold a significant portion of the stock, and several firms have recently adjusted their price targets.
Cross Country Healthcare (CCRN) HR chief sells 6,200 shares
Cross Country Healthcare's Chief Human Resources Officer, Colin Patrick McDonald, sold 6,200 shares of common stock on March 11, 2026, in an open-market transaction at a weighted average price of approximately $9.70 per share. Following this sale, McDonald directly holds 28,060 shares of the company's common stock. This insider transaction was disclosed in a Form 4 SEC filing.
Cross Country names new chief accounting officer after execs step down
Cross Country Healthcare announced that two executives, Chief Accounting Officer James Redd III and Chief Information Officer Phil Noe, have stepped down. The company has appointed Marvin Veizaga, a veteran who joined in 2015, as the new chief accounting officer. These changes follow January's announcement of founder Kevin Clark returning as president and CEO, after the previous CEO, John Martins, departed following the cancellation of a proposed sale to Aya Healthcare.
Does Cross Country Healthcare (CCRN) Have Strong Fundamentals?
Long Cast Advisers, an investment firm, discussed Cross Country Healthcare, Inc. (NASDAQ: CCRN) in its Q4 2025 investor letter, noting their recent purchase of the nurse staffing company. Despite the firm's belief in the stock being undervalued with significant cash reserves, Cross Country Healthcare is not among the 40 most popular hedge fund stocks, and the article suggests that certain AI stocks may offer higher and quicker returns for investors.
Cross Country Healthcare’s Deal Risks: Terminated Aya Merger Highlights Acquisition Pitfalls and Financial Exposure
Cross Country Healthcare (CCRN) faces significant acquisition risks, as highlighted by the terminated Aya Merger, which cost the company a $20 million termination fee. The article suggests that future strategic transactions could lead to financial exposure through unrecovered costs, integration challenges, loss of key personnel or customers, increased debt, and regulatory liabilities. Wall Street analysts currently hold a "Hold" consensus rating on CCRN stock.
Cross Country names new chief accounting officer after execs step down
Cross Country Healthcare (NASDAQ: CCRN) has appointed Marvin Veizaga as its new chief accounting officer after two executives, James Redd III and Phil Noe, stepped down. Veizaga, who was previously group VP, corporate controller, has been with the firm since 2015. This leadership change follows Kevin Clark's return as president and CEO in January, and the cancellation of a proposed sale to Aya Healthcare.
Cross Country Healthcare and Open Hearts for Orphans Announce Community Partnership to Strengthen Families and Support Vulnerable Children
Cross Country Healthcare has announced a new community partnership with Open Hearts for Orphans (OHFO), a South Florida nonprofit dedicated to supporting vulnerable children and families. This collaboration aims to leverage community engagement, employee involvement, and strategic initiatives to strengthen families and improve outcomes for children, reflecting a shared commitment to people-centered values. Both organizations believe that strong families are crucial for healthy communities.
Healthcare workforce company teams with nonprofit to help vulnerable kids
Cross Country Healthcare, Inc. (Nasdaq: CCRN) has partnered with Open Hearts for Orphans (OHFO), a South Florida nonprofit, to support vulnerable children and strengthen families. This collaboration will involve community engagement, employee involvement, and strategic initiatives, reflecting a shared commitment to people-centered values. Both organizations aim to create a measurable impact for children and families.
Gabelli Funds LLC Has $5.22 Million Stock Position in Cross Country Healthcare, Inc. $CCRN
Gabelli Funds LLC significantly reduced its stake in Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 23.7% in the third quarter, now holding 367,284 shares valued at $5.22 million. Other institutional investors also adjusted their positions in CCRN. The company recently reported an earnings per share of ($0.06), missing consensus estimates, and analysts currently maintain a "Hold" rating for the stock with an average price target of $12.03.
Cross Country Healthcare and Open Hearts for Orphans Announce Community Partnership to Strengthen Families and Support Vulnerable Children
Cross Country Healthcare, a technology-driven healthcare workforce solutions company, has announced a community partnership with Open Hearts for Orphans (OHFO), a nonprofit dedicated to supporting vulnerable children. This collaboration aims to strengthen families and communities through employee engagement, awareness-building, and strategic initiatives, aligning with both organizations' shared values and commitment to people-centered care. Both companies believe in the foundational role of strong families for healthy communities and will work together to create a measurable impact for children.
Cross Country Healthcare 2025 Annual Report: AI-Powered Workforce Solutions, Risk Factors, and Corporate Social Responsibility 3346
Cross Country Healthcare, Inc. (CCH) has released its 2025 Annual Report, highlighting the termination of the Aya Merger Agreement, a subsequent receipt of a $20 million termination fee, and the reappointment of Kevin C. Clark as President and CEO. The report emphasizes the company's strategic investments in technology, its commitment to corporate social responsibility, and outlines significant business, economic, and operational risks for investors to consider. These developments, particularly the leadership change and failed merger, are identified as potentially material events impacting the company's future direction and stock valuation.
Cross Country Healthcare 2025 10-K: Revenue $1.05B, Net Loss $94.9M
Cross Country Healthcare reported a significant financial downturn in its 2025 10-K filing, with revenues of $1.05 billion representing a 21.6% year-over-year decline. The company posted a net loss of $94.9 million, primarily due to a $77.9 million impairment charge. These results indicate challenges in their traditional staffing channels, though home-based staffing showed growth.
Cross Country Healthcare, Inc. $CCRN Shares Sold by GABELLI & Co INVESTMENT ADVISERS INC.
GABELLI & Co INVESTMENT ADVISERS INC. has reduced its stake in Cross Country Healthcare (NASDAQ:CCRN) by 42.9%, selling 178,300 shares and retaining 236,850 shares worth approximately $3.36 million. This move comes after Cross Country Healthcare missed its Q3 earnings expectations, reporting an EPS of ($0.06) against an expected $0.03 and revenues of $236.76M versus an expected $254.3M. Analysts currently hold a consensus "Hold" rating for the stock with an average price target of $12.03.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q4 2025 Earnings Call Transcript
Cross Country Healthcare, Inc. (NASDAQ:CCRN) released its Q4 2025 earnings call transcript, reporting missed earnings expectations with an EPS of $-2.56476 against an expectation of $0.03. CEO Kevin Clark outlined a strategy for renewed growth, focusing on operational rigor, technology-powered solutions like Intellify and Xperience, and disciplined capital allocation, aiming for revenue run rate north of $1 billion and adjusted EBITDA margins of 4% to 5% by the end of 2026. The company plans to expand its market share, leverage its strong balance sheet for strategic investments including potential accretive acquisitions in home-based staffing and locums, and continue to optimize costs by expanding its India-based center of excellence and adopting AI.
Cross Country Healthcare (CCRN) Quarterly Loss Of US$82.9 Million Tests Earnings Recovery Narrative
Cross Country Healthcare (CCRN) reported a Q4 2025 net loss of US$82.9 million and an annual loss of US$94.9 million, with revenue declining to US$236.8 million. These results challenge the narrative of strong earnings growth and a swift path to profitability, with critics pointing to sustained losses and margin pressures. Despite analyst expectations for growth in specific segments, investors are questioning the company's ability to stabilize bill rates and offset weaknesses in Travel Nursing.
Cross Country Healthcare Q4 2025 Results: Reports Quarterly and Annual Loss - News and Statistics
Cross Country Healthcare Inc. reported a significant quarterly loss of $82.9 million, or $2.56 per share, for Q4 2025, with an adjusted loss of 6 cents per share, missing analyst expectations. The healthcare staffing firm's annual loss totaled $94.9 million, or $2.93 per share, on revenue of $1.05 billion. For the current quarter ending in March, the company expects a per-share loss between 4 and 6 cents, with revenue projected to be $235 million to $240 million.
Cross Country Healthcare (CCRN) swings to larger 2025 loss as revenue falls
Cross Country Healthcare (CCRN) reported a significant net loss of $94.9 million for the full year 2025, compared to a $14.6 million loss in 2024, mainly due to softer demand for healthcare staffing and non-cash charges like a $77.9 million goodwill impairment after the termination of the Aya merger agreement. Revenue decreased by 22% to $1.05 billion, and adjusted EBITDA fell by 45% to $26.8 million. The company projects continued weakness for Q1 2026, with revenue expected to decline further, despite maintaining a strong balance sheet with $108.7 million in cash and no debt.
Cross Country Healthcare (NASDAQ:CCRN) Raised to Buy at Benchmark
Benchmark upgraded Cross Country Healthcare (CCRN) from "hold" to "buy" with a $14 price target, suggesting a significant upside despite the company missing Q4 expectations with a 23-24% YoY revenue drop and weak Q1 guidance. The stock had previously declined by about 14% intraday following the Q4 earnings report. Institutional ownership is high at around 96%, with major holders like Goldman Sachs increasing their stakes, and recent insider buying along with a cash cushion of approximately $108.7 million is seen as providing downside support.
Citizens reiterates Cross Country Healthcare stock rating on 4Q results
Citizens reiterated a "Market Outperform" rating and an $11.00 price target for Cross Country Healthcare (NASDAQ: CCRN) following the company's fourth-quarter 2025 results. Despite revenue and EBITDA falling short of estimates, the stock is considered undervalued with strong liquidity as the company holds more cash than debt. Investors are focusing on the company's strategic priorities under new CEO Kevin Clark and plans for future growth.
Cross Country: Q4 Earnings Snapshot
Cross Country Healthcare Inc. reported a significant loss of $82.9 million in its fourth quarter, translating to a loss of $2.56 per share, or 6 cents per share when adjusted for one-time items. These results, along with revenue of $236.8 million, fell short of Wall Street expectations. The company also provided a grim outlook for the current quarter, anticipating a further loss and lower revenue.
Cross Country: Fourth Quarter Financial Results Overview
Cross Country Healthcare Inc. reported a net loss of $82.9 million, or $2.56 per share, for the fourth quarter, missing analysts' expectations. After adjusting for nonrecurring items, the loss was 6 cents per share. The company's revenue of $236.8 million also fell short of projections, and for the full year, it posted a net loss of $94.9 million on $1.05 billion in revenue.
Cross Country Healthcare Reports 2025 Results Amid Market Challenges
Cross Country Healthcare (CCRN) reported a significant decline in revenue and wider net losses for Q4 and full-year 2025, largely due to impairment charges and softer staffing demand. Despite these challenges, the company maintained strong liquidity, adopted its Intellify platform, reduced U.S. headcount, and repurchased shares, while working to reset its strategy after a terminated merger. An AI Analyst from TipRanks rates CCRN as Neutral, citing weak financial performance and bearish technical indicators.
